HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Konstantinos Tziomalos Selected Research

Spironolactone (Aldactone)

7/2021The Role of Finerenone in the Management of Diabetic Nephropathy.
3/2008Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
1/2007Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Konstantinos Tziomalos Research Topics

Disease

30Stroke (Strokes)
01/2021 - 07/2007
27Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 01/2006
26Ischemic Stroke
12/2021 - 01/2004
22Non-alcoholic Fatty Liver Disease
10/2021 - 05/2006
20Hypertension (High Blood Pressure)
10/2019 - 08/2005
17Coronary Disease (Coronary Heart Disease)
01/2019 - 01/2007
16Type 2 Diabetes Mellitus (MODY)
04/2022 - 03/2008
16Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2020 - 01/2009
16Obesity
12/2018 - 08/2005
14Insulin Resistance
04/2022 - 02/2007
14Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 01/2007
13Overweight
12/2018 - 01/2010
11Atherosclerosis
04/2022 - 04/2007
11Heart Failure
05/2020 - 02/2006
11Weight Loss (Weight Reduction)
05/2020 - 01/2009
10Inflammation (Inflammations)
06/2017 - 04/2008
9Body Weight (Weight, Body)
11/2021 - 05/2006
8Fibrosis (Cirrhosis)
10/2021 - 06/2005
8Diabetes Mellitus
05/2020 - 06/2009
8Chronic Renal Insufficiency
01/2018 - 07/2009
8Chronic Hepatitis B
02/2015 - 06/2005
7Dyslipidemias (Dyslipidemia)
01/2019 - 09/2010
6Atrial Fibrillation
11/2018 - 07/2007
6Vascular Diseases (Vascular Disease)
01/2011 - 11/2008
5Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022 - 01/2016
4Diabetic Nephropathies (Diabetic Nephropathy)
07/2021 - 04/2015
4Infections
11/2018 - 05/2015
4Acute Coronary Syndrome
05/2015 - 01/2009
4Liver Diseases (Liver Disease)
10/2014 - 10/2009
4Unstable Angina
09/2013 - 11/2007
4Myocardial Infarction
09/2013 - 11/2007
3Hypoglycemia (Reactive Hypoglycemia)
11/2021 - 08/2020
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2021 - 01/2018
3Alcoholic Fatty Liver
10/2021 - 11/2016
3Thrombosis (Thrombus)
05/2020 - 11/2010
3Hyperlipidemias (Hyperlipidemia)
01/2019 - 01/2006
3Liver Cirrhosis (Hepatic Cirrhosis)
09/2017 - 02/2006
3Vascular Calcification
05/2017 - 04/2008
3Essential Hypertension
02/2014 - 09/2006
3Glucose Intolerance
04/2013 - 01/2010
3Atherosclerotic Plaque (Atheroma)
07/2010 - 03/2007
3Abdominal Obesity
01/2010 - 02/2007
3Hyperaldosteronism (Conn Syndrome)
09/2008 - 01/2007
2Weight Gain
10/2020 - 03/2008

Drug/Important Bio-Agent (IBA)

48Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 01/2006
28LipidsIBA
12/2021 - 02/2007
25Glucose (Dextrose)FDA LinkGeneric
05/2021 - 08/2005
17LDL CholesterolIBA
12/2021 - 05/2006
14Triglycerides (Triacylglycerol)IBA
10/2021 - 05/2006
14Atorvastatin (Lipitor)FDA Link
09/2013 - 05/2006
13oxidized low density lipoproteinIBA
12/2021 - 02/2007
12Metformin (Glucophage)FDA LinkGeneric
02/2020 - 05/2006
11HDL CholesterolIBA
01/2018 - 01/2007
10Insulin (Novolin)FDA Link
11/2021 - 02/2007
10Orlistat (Xenical)FDA Link
12/2018 - 05/2006
10Antihypertensive Agents (Antihypertensives)IBA
01/2017 - 02/2007
8AdipokinesIBA
10/2019 - 01/2010
8AndrogensIBA
12/2018 - 02/2012
7Hypoglycemic Agents (Hypoglycemics)IBA
10/2020 - 03/2008
7Pharmaceutical PreparationsIBA
09/2017 - 08/2005
7Uric Acid (Urate)IBA
06/2013 - 01/2007
6Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2021 - 04/2007
6Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2006
6Lamivudine (Epivir)FDA Link
01/2010 - 06/2005
5Ezetimibe (Zetia)FDA Link
12/2017 - 02/2008
5Fibric Acids (Fibrates)IBA
01/2015 - 01/2006
5CholesterolIBA
04/2013 - 05/2006
4Angiotensin Receptor AntagonistsIBA
07/2021 - 02/2007
4Glucagon-Like Peptide-1 Receptor AgonistsIBA
10/2020 - 01/2015
4AdiponectinIBA
10/2019 - 01/2012
4ResistinIBA
10/2019 - 01/2012
4LeptinIBA
10/2019 - 01/2012
4DiureticsIBA
01/2019 - 11/2010
4Pioglitazone (Actos)FDA Link
01/2018 - 03/2008
4Transaminases (Aminotransferases)IBA
01/2018 - 11/2013
4Proprotein Convertase 9IBA
01/2017 - 01/2015
4IronIBA
01/2014 - 02/2006
4sibutramine (Meridia)FDA Link
10/2013 - 01/2009
4Hepatitis B e AntigensIBA
01/2010 - 06/2005
3Antiviral Agents (Antivirals)IBA
04/2022 - 03/2010
3Sodium-Glucose Transporter 2 InhibitorsIBA
11/2021 - 01/2018
3Spironolactone (Aldactone)FDA LinkGeneric
07/2021 - 01/2007
3Eplerenone (Inspra)FDA LinkGeneric
07/2021 - 01/2007
3SodiumIBA
05/2020 - 07/2019
3C-Reactive ProteinIBA
01/2019 - 05/2006
3Anti-Obesity Agents (Antiobesity Drugs)IBA
12/2018 - 01/2010
3PCSK9 InhibitorsIBA
01/2017 - 01/2016
3Quinapril (Accupril)FDA LinkGeneric
01/2017 - 11/2011
3Adrenal Cortex Hormones (Corticosteroids)IBA
10/2016 - 11/2005
3Dipeptidyl-Peptidase IV InhibitorsIBA
11/2015 - 04/2014
3Atenolol (Tenormin)FDA LinkGeneric
02/2014 - 09/2006
2Lipoprotein(a)IBA
01/2022 - 07/2009
2Sodium-Glucose Transport ProteinsIBA
11/2021 - 01/2018
2Mineralocorticoid Receptor AntagonistsIBA
07/2021 - 01/2018

Therapy/Procedure

18Therapeutics
04/2022 - 04/2006
11Secondary Prevention
12/2021 - 01/2006
7Drug Therapy (Chemotherapy)
08/2020 - 11/2005
4Glycemic Control
10/2020 - 01/2009
3Renal Dialysis (Hemodialysis)
01/2019 - 07/2009
3Bariatric Surgery
01/2018 - 01/2010